BLB&B Advisors LLC Has $778,000 Stake in The Cigna Group (NYSE:CI)

BLB&B Advisors LLC raised its stake in shares of The Cigna Group (NYSE:CIFree Report) by 2.0% in the third quarter, Holdings Channel.com reports. The firm owned 2,245 shares of the health services provider’s stock after buying an additional 43 shares during the period. BLB&B Advisors LLC’s holdings in The Cigna Group were worth $778,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in CI. Cedar Wealth Management LLC bought a new position in shares of The Cigna Group during the 1st quarter worth approximately $29,000. TruNorth Capital Management LLC bought a new position in shares of The Cigna Group during the 2nd quarter worth approximately $33,000. Ulland Investment Advisors LLC lifted its position in shares of The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after buying an additional 100 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. bought a new position in shares of The Cigna Group during the 2nd quarter worth approximately $66,000. Finally, Private Ocean LLC lifted its position in shares of The Cigna Group by 29.9% during the 2nd quarter. Private Ocean LLC now owns 200 shares of the health services provider’s stock worth $66,000 after buying an additional 46 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Activity

In other news, Director William J. Delaney III sold 2,691 shares of the business’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the completion of the transaction, the director now directly owns 17,539 shares in the company, valued at $6,010,264.52. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Barclays lifted their target price on shares of The Cigna Group from $393.00 to $405.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Jefferies Financial Group lifted their price target on shares of The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a report on Tuesday, September 17th. Stephens reaffirmed an “overweight” rating and issued a $410.00 price target on shares of The Cigna Group in a report on Friday, August 2nd. JPMorgan Chase & Co. lifted their price target on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a report on Wednesday, August 21st. Finally, Piper Sandler began coverage on shares of The Cigna Group in a report on Wednesday, June 26th. They issued an “overweight” rating and a $400.00 price target on the stock. One equities research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, The Cigna Group presently has an average rating of “Buy” and a consensus target price of $392.79.

View Our Latest Research Report on The Cigna Group

The Cigna Group Trading Down 0.9 %

Shares of CI stock opened at $317.46 on Wednesday. The company’s fifty day simple moving average is $350.20 and its two-hundred day simple moving average is $343.58. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.71 and a quick ratio of 0.71. The Cigna Group has a 1 year low of $253.95 and a 1 year high of $370.83. The stock has a market capitalization of $90.18 billion, a price-to-earnings ratio of 26.06, a PEG ratio of 1.05 and a beta of 0.50.

The Cigna Group (NYSE:CIGet Free Report) last issued its earnings results on Thursday, August 1st. The health services provider reported $6.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.42 by $0.30. The business had revenue of $60.52 billion for the quarter, compared to analysts’ expectations of $58.30 billion. The Cigna Group had a net margin of 1.70% and a return on equity of 17.83%. The business’s revenue for the quarter was up 24.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.13 EPS. As a group, analysts anticipate that The Cigna Group will post 28.48 earnings per share for the current year.

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.